Myopia: Slowing Progression
Myopia, or nearsightedness, is more than just about getting your new glasses—it’s a chronic, progressive disease that can pose long-term risks to ocular health. With the global prevalence of myopia rising significantly, especially among children, early and proactive intervention has never been more critical.
At Fab Eye Care Center, we offer clinically proven myopia control treatments, including the fitting of FDA-approved MiSight® 1 day soft contact lenses, to help slow the progression of myopia and protect long-term visual health.
Understanding the Risks of Progressive Myopia
Children with progressing myopia are at a significantly higher risk of developing serious eye conditions later in life, such as:
High Myopes Have Increased Risk of disease such as:
- 7x more often get Retinal detachment
- 40x more often get Myopic maculopathy
- 4x more often get Glaucoma
- 3x more often get Cataracts earlier in life
These risks increase as myopia advances, making early diagnosis and evidence-based management essential.
MiSight® 1 Day: FDA-Approved Myopia Control
Fab Eye Care Center is proud to be certified to fit MiSight® 1 day contact lenses—the first and only FDA-approved soft contact lens proven to slow the progression of myopia in children aged 8 to 12 at the initiation of treatment. Clinical studies have shown that MiSight® lenses can reduce myopia progression by up to 59% over a three-year period, compared to single-vision lenses.
Comprehensive Myopia Management at Fab Eye Care
In addition to MiSight® lenses, Fab Eye Care Center offers a comprehensive approach to myopia control, which may include:
- Low-dose atropine therapy
- Multifocal glasses
- Lifestyle counseling to support healthy visual habits
- Regular axial length monitoring and personalized treatment plans
Our team uses advanced diagnostic tools to carefully monitor and manage each child’s visual development, ensuring the best possible outcomes.
Schedule a Consultation Today
